S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
NYSEARCA:BTAL

AGF U.S. Market Neutral Anti-Beta Fund (BTAL) Price, Holdings, & News

$19.01
+0.12 (+0.64%)
(As of 04/17/2024 ET)
Today's Range
$18.84
$19.01
50-Day Range
$17.85
$19.01
52-Week Range
$16.59
$21.39
Volume
180,187 shs
Average Volume
246,604 shs
Market Capitalization
$229.07 million
Assets Under Management
$224.61 million
Dividend Yield
1.10%
Net Expense Ratio
1.54%
BTAL stock logo

About AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

BTAL Stock Price History

BTAL ETF News Headlines

Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Federated Hermes MDT Market Neutral Fund;A
Victory Market Neutral Income Fund;I
BTAL: A Smart Way To Hedge The Market
Vanguard Market Neutral Fund;Investor
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
See More Headlines
Receive BTAL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AGF U.S. Market Neutral Anti-Beta Fund and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
AGF Investments
Fund Name
AGF U.S. Market Neutral Anti-Beta Fund
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:BTAL
Inception Date
9/13/2011
Fund Manager
William DeRoche, Philip Lee, Josh Belko
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Long/Short
Development Level
Developed Markets
Region
North America
Number of Holdings
631

Fund Statistics

Assets Under Management
$224.61 million
Average Daily Volume
$326,473.00
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Chase Bank, N.A.
Advisor
AGF Investments LLC
Custodian
J.P. Morgan Chase Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
J.P. Morgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
1
Put Options
2
Call Options
1
Short Interest
117,800 shs

Miscellaneous

Beta
-0.51
Creation Unit
50,000
Creation Fee
$1,500.00
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

AGF U.S. Market Neutral Anti-Beta Fund Expenses

TypeBTALLong/Short ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.45%0.83%0.54%0.50%0.51%
Other Expenses1.61%1.90%0.54%0.64%0.58%
Total Expense2.06%2.08%0.70%0.74%0.70%
Fee Waiver-0.52%-2.39%-0.55%-0.68%-0.57%
Net Expense1.54%1.03%0.60%0.57%0.58%

AGF U.S. Market Neutral Anti-Beta Fund (BTAL) Holdings & Exposure

BTAL Sector Exposure

BTAL Industry Exposure


BTAL ETF - Frequently Asked Questions

How have BTAL shares performed in 2024?

AGF U.S. Market Neutral Anti-Beta Fund's stock was trading at $16.95 on January 1st, 2024. Since then, BTAL stock has increased by 12.2% and is now trading at $19.01.
View the best growth stocks for 2024 here
.

What does BTAL invest in?

AGF U.S. Market Neutral Anti-Beta Fund is a equity fund issued by AGF Investments. BTAL focuses on long/short investments. The fund's investments total to approximately $224.61 million assets under management.

What stocks does AGF U.S. Market Neutral Anti-Beta Fund hold?
What is the management fee for AGF U.S. Market Neutral Anti-Beta Fund?

AGF U.S. Market Neutral Anti-Beta Fund's management fee is 0.45% and has other expenses of 1.61%. However, BTAL has a fee waiver of -0.52% to reimburse the expenses. The net expense ratio for BTAL is 1.54%.

What other stocks do shareholders of AGF U.S. Market Neutral Anti-Beta Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AGF U.S. Market Neutral Anti-Beta Fund investors own include Ajinomoto (AJINY), Advanced Energy Industries (AEIS), Autodesk (ADSK), Koninklijke Ahold Delhaize (ADRNY), Accenture (ACN), American Campus Communities (ACC), Abbott Laboratories (ABT), AbbVie (ABBV), AAON (AAON).

Who are AGF U.S. Market Neutral Anti-Beta Fund's major shareholders?

AGF U.S. Market Neutral Anti-Beta Fund's stock is owned by a variety of retail and institutional investors. Top institutional investors include Worth Asset Management LLC (0.34%).

How do I buy shares of AGF U.S. Market Neutral Anti-Beta Fund?

Shares of BTAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:BTAL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners